Advanced Research Projects Agency for Health

for brain research, but that also taps into a consortium across the country of 35 different institutions.

So, yes, there's collaboration here, but ARPA-H is another example, a national collaboration.

The customer experience sub is here in Dallas, but it was a statewide effort to get it here, and the hub site is here at Pegasus Park.

That's accelerating all kinds of advancements, and it's really exciting.

UT Southwestern right now is working on 3D printing of a liver through ARPA-H, one of those things.

So that's, it's really exciting seeing that come to life.

I could literally go on and on.

The solicitation of new nominees could allow the committee to resume its work early next year.

Final news today, where Alicia Jackson, the director of the Advanced Research Projects Agency for Health, or ARPA-H, has been placed on administrative leave.

Jackson, a former health technology industry executive, has led ARPA-H for a little more than a year.

She had previously sought a limited conflict of interest waiver based on her financial interests, but it remains unclear whether the waiver has been finalized or granted.

ARPA-H Chief Medical Officer Dr. Rafid Fadul is assuming the duties of Director in Jackson's absence as the U.S. Department of Health and Human Services resolves issues in her ethics clearance process.

Thanks again for tuning into this week's episode of Health on the Hill, brought to you by Heart Health Strategies.

For more information on this week's healthcare happenings in the administration and on Capitol Hill, you can visit our website at HHS.com and click on the news section at the top of the page.

And one of my former PhD students, UC San Diego, Tanya Roymoto, is making teeny tiny ones that are just a millimeter or two in diameter that are going to be sent into the brain to treat stroke.

And in fact, ARPA-H, which is the Advanced Research Projects Agency for Health, for people that know DARPA, it's like DARPA for health, they have about a $25 million grant to actually use this to get into the brain and treat strokes, treat thrombosis before they cause a stroke, which is really exciting.

Why are these also considered robots? Why not a mechanical device? How do you actually make that definition?

That's a great question.

Ladies and gentlemen, in about 24 minutes from now, at the top of the hour, at 12 noon EST, we will be having a discussion with Centillion and Pace.

They are kind of going in together on an ARPA-H Give Award, where they are basically...

They got a bunch of money to go after individualized production of therapeutics.

Again, this is hot on the heels of everything that's happening inside of the FDA space where a bunch of new rules have just been made whereby you can – make these personalized therapies for a given disease.

So stick around for that conversation that we'll be having in about 20 minutes or so.

So we're very excited for that.

If you have any questions for the Centillion team or the PACE team ahead of time or questions about ARPA-H, feel free to put them in the chat.

And we'll get to those once we are in conversation with them.

But speaking of MAGA crime, another Trump official just was just caught lining her pockets.

So ProPublica has been doing a lot of good work, reports that Alicia Jackson, who runs ARPA-H, it's a health research agency with a billion and a half dollar budget that hands out grants.

Trump put her there last October and Before that, she founded a company called EverNow, which sells menopause treatment online.

In November, she stood at the HHS podium and endorsed the government's decision to remove safety warnings from hormone therapy.

I'd like to transition a little bit to just talking about the future.

And we just announced, congratulations, this large ARPA-H funded consortium focused on intrinsically disordered proteins that you're co-leading called SEEDS.

Tell me a little bit about SEEDS, what it's hoping to do, sort of its long-term goals.

Yeah, so also congratulations to you because Nautilus is our partner in this consortium.

35.

ARPA-H announces four focus areas FOR funding The Advanced Research Projects Agency for Health, ARPA-H, announces its first four focus areas for funding opportunities.

36.

Startup interview with Otto Kasymov, CEO and co-founder of Zentist 37.

Yeah, that's right.

And now I will say we are tightly aligned with ARPA-H and very supportive of what they've done.

So for those who are on the call who have not heard, right, they have gone through and taken a very different approach than we have where we've opened up the field.

Anybody can compete, develop therapeutics, and use that as a big carrot for people to chase.

ARPA-H is taking a different track where they have selected an endpoint for qualification.

And then they built the infrastructure around that endpoint for qualification and build the evidence base.

So they have now a submission for a qualified endpoint around intrinsic capacity.